PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Diabetes Research Unit, Swansea University Medical School and Swansea Bay University Health Board, Swansea, UK.\', \'Faculté de Santé, Université de Paris, Paris, France.\', \'Assistance Publique-Hôpitaux de Paris (AP-HP), Service de Nutrition, Centre Spécialisé Obésité, Hôpital Européen Georges Pompidou, Paris, France.\', \'INSERM, UMR1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Paris, France.\', \'Incentive Denmark, Holte, Denmark.\', \'Novo Nordisk North West Europe Pharmaceuticals A/S, Copenhagen, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/03007995.2020.1862775
?:hasPublicationType
?:journal
  • Current medical research and opinion
is ?:pmid of
?:pmid
?:pmid
  • 33306421
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.944
?:rankingScore_hIndex
  • 96
is ?:relation_isRelatedTo_publication of
?:title
  • Costs of COVID-19 pandemic associated with diabetes in Europe: a health care cost model.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all